XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Cash flows from operating activities:      
Net income (loss) $ 264 $ 171  
Adjustments to reconcile net income (loss) to net cash flows from operating activities:      
Impairments and other charges 22 0  
Depreciation, depletion and amortization 232 226  
Changes in assets and liabilities:      
Receivables (368) (145)  
Accounts payable 207 205  
Inventories (225) (1)  
Other operating activities (95) (186)  
Total cash flows provided by operating activities (50) 203  
Cash flows from investing activities:      
Capital expenditures (189) (104)  
Proceeds from sales of property, plant and equipment 56 58  
Other investing activities (22) (16)  
Total cash flows used in investing activities (155) (62)  
Cash flows from financing activities:      
Payments on long-term borrowings (640) (188)  
Dividends to shareholders (108) (40)  
Other financing activities 80 5  
Total cash flows used in financing activities (668) (223)  
Effect of exchange rate changes on cash (17) (35)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (890) (117)  
Cash and equivalents at beginning of period 3,044 2,563 $ 2,563
Cash and equivalents at end of period     3,044
Cash and equivalents at end of period 2,154 2,446 $ 3,044
Cash payments during the period for:      
Interest 261 138  
Income taxes $ 78 54  
Maximum Percentage Gross Trade Receivables From One Customer 10.00%   10.00%
Increase (Decrease) in Employee Related Liabilities $ (87) $ (67)  
UNITED STATES | Accounts Receivable [Member] | Geographic Concentration Risk [Member]      
Cash payments during the period for:      
Concentration Risk, Percentage 35.00%   34.00%
MEXICO | Accounts Receivable [Member] | Geographic Concentration Risk [Member]      
Cash payments during the period for:      
Concentration Risk, Percentage 12.00%   11.00%